• 2,2,2-Trichloroethanol: Small Molecule Biochemical for Prote

  2026-06-08

  2,2,2-Trichloroethanol empowers protein analysis workflows and molecular biology research in ways standard reagents cannot, enabling rapid, sensitive detection and workflow optimization. Its high solubility and purity from APExBIO support reproducible, data-driven advances in dopaminergic neuron studies and beyond.

• Trilaurin (Glycerol Tridodecanoate): Applied Workflows & Pro

  2026-06-08

  Trilaurin (Glycerol Tridodecanoate) is a versatile lipid excipient enabling advanced drug delivery, reproducible biocatalytic synthesis, and cosmetic formulation. Distinct in its lack of skin sensitization and high yield in enzymatic workflows, Trilaurin from APExBIO stands out for formulation reliability and experimental flexibility.

• Iptacopan (LNP023): Applied Workflows in Complement Research

  2026-06-07

  Iptacopan (LNP023) empowers researchers to selectively inhibit the alternative complement pathway in both in vitro and in vivo models, delivering precise control over complement activation. This article details advanced use-cases, protocol enhancements, and troubleshooting strategies, translating recent reference findings into actionable workflows for complement-mediated disease research.

• Anti-HMGB1 Rabbit Monoclonal Antibody: Technical Use Guide

  2026-06-06

  The Anti-HMGB1 Rabbit Monoclonal Antibody (MA3057) provides a validated, species-cross-reactive tool for precise detection of HMGB1 protein in human, mouse, and rat research samples. It is designed for use in Western blot, immunohistochemistry, and flow cytometry workflows targeting chromatin protein studies, but is not validated for diagnostic or therapeutic applications.

• Optimizing Cancer Epigenetics with GSK126 EZH2 Inhibitor (SK

  2026-06-05

  This article delivers scenario-driven, evidence-based guidance on deploying GSK126 EZH2 inhibitor (SKU A3446) for robust, reproducible epigenetic assays in cancer research. By addressing common laboratory challenges and contrasting real-world solutions, it demonstrates how this selective small molecule from APExBIO empowers workflows in oncology and functional genomics.

• Microfluidized Dextran–Trilaurin LNP System for Oral Colon C

  2026-06-05

  This study presents a hierarchically targeted oral delivery system combining microfluidized dextran microgels and trilaurin-based lipid nanoparticles to co-deliver cisplatin and SPIONs for localized colon cancer treatment. The approach demonstrates enhanced tumor targeting, improved drug retention in the colon, and effective dual chemo-magnetothermal therapy, with implications for peptide/protein drug oral delivery and nanoparticle-based cancer therapeutics.

• Technical Guide: FITC-Concanavalin A (ConA) Conjugate Applic

  2026-06-04

  FITC-Concanavalin A (ConA) Conjugate enables targeted detection of cell surface α-D-glucose and α-D-mannose residues in immunofluorescence and flow cytometry workflows. It should be used exclusively for carbohydrate-binding applications, and not for non-glycan targets or outside its defined storage and stability parameters.

• Biomimetic Chromatography for Modeling Pulmonary Drug Permea

  2026-06-04

  This study pioneers the use of IAM-LC and OT-CEC coupled with mass spectrometry to model lung permeability for pharmaceuticals, offering robust high-throughput screening strategies. The findings provide mechanistic insight into drug–membrane interactions and demonstrate the translational value of biomimetic chromatographic methods in antiretroviral and permeability research.

• Applied ddATP: Precision DNA Synthesis Termination in Resear

  2026-06-03

  ddATP (2',3'-dideoxyadenosine triphosphate) is transforming DNA synthesis termination assays, offering unmatched control in Sanger sequencing, PCR termination, and DNA repair workflows. Discover actionable protocols, troubleshooting insights, and experimental enhancements leveraging APExBIO's ddATP for reliable, reproducible results.

• Gamithromycin (ML-1709460): Protocols & Optimization in Resp

  2026-06-03

  Gamithromycin (ML-1709460) delivers precision and translational power for respiratory disease models in veterinary research, with protocol refinements driven by recent PK/PD breakthroughs. This article distills cutting-edge findings into actionable steps for bench workflows, troubleshooting, and dose optimization, enabling superior outcomes for both Pasteurella multocida and Streptococcus suis infection studies.

• Toremifene: Applied Workflows for Prostate Cancer Research

  2026-06-02

  Toremifene, a potent second-generation selective estrogen-receptor modulator, empowers researchers to dissect hormone-dependent pathways and metastatic mechanisms in prostate cancer. This guide delivers actionable protocols, troubleshooting insights, and integrative workflow enhancements drawn from the latest peer-reviewed advances—including the pivotal TSPAN18/STIM1 axis.

• HyperScript RT SuperMix for qPCR: Precision in Complex RNA A

  2026-06-02

  HyperScript™ RT SuperMix for qPCR delivers robust, reproducible cDNA synthesis even from low-concentration and structurally complex RNA templates. Its thermal-stable enzyme and optimized primer blend streamline two-step qRT-PCR workflows, enabling high-fidelity gene expression analysis in demanding research settings.

• Trilaurin (Glycerol Tridodecanoate) in Drug Delivery Workflo

  2026-06-01

  Trilaurin stands out as a multifaceted lipid excipient, uniquely positioned for advanced biocatalytic synthesis and targeted oral drug delivery. By leveraging its chemical properties and proven compatibility with solid lipid nanoparticles, researchers gain both workflow reliability and enhanced therapeutic outcomes.

• NET Formation in CML: Differential Effects of Tyrosine Kinas

  2026-06-01

  This article reviews recent evidence that neutrophil extracellular trap (NET) formation is elevated in chronic myeloid leukemia (CML) and is differentially modulated by tyrosine kinase inhibitors (TKIs). The findings provide mechanistic insights into vascular toxicity risks in CML therapy and offer guidance for translational research using kinase inhibitors.

• Troglitazone: Strategic PPARγ Agonist for Translational Impa

  2026-05-31

  Explore how Troglitazone’s PPARγ/α dual activity uniquely empowers translational researchers to bridge metabolic and tumor immunology, with actionable guidance for experimental design and emerging insights into SPP1-targeted oncology.

16476 records 1/1099 page Next 12345 下5页 Last page